By Dr. Niti RaizadaCancer is a heterogeneous group of diseases rather than a single entity. Even when it affects the same organ, it can take different forms that have ...
Dr Reddy's Laboratories (DRL) has joined the race to acquire the biosimilar products portfolio of US-based Biogen in a transaction worth a potential $1 billion, according to two people ...